Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Though heterozygous mutations in MITF are a major cause for Waardenburg syndrome type 2 (WS2), homozygous mutations in this gene and the associated phenotype have been rarely characterized.
|
30549420 |
2019 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Wnt signaling pathway involvement in genotypic and phenotypic variations in Waardenburg syndrome type 2 with MITF mutations.
|
29531335 |
2018 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Functional analysis of a nonstop mutation in MITF gene identified in a patient with Waardenburg syndrome type 2.
|
28356565 |
2017 |
Waardenburg Syndrome Type 2
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Functional analysis of a nonstop mutation in MITF gene identified in a patient with Waardenburg syndrome type 2.
|
28356565 |
2017 |
Waardenburg Syndrome Type 2
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Molecular etiology and genotype-phenotype correlation of Chinese Han deaf patients with type I and type II Waardenburg Syndrome.
|
27759048 |
2016 |
Waardenburg Syndrome Type 2
|
0.800 |
Biomarker
|
disease |
CLINGEN |
A de novo silencer causes elimination of MITF-M expression and profound hearing loss in pigs.
|
27349893 |
2016 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Because mutations in MITF are causative of Waardenburg syndrome type 2 (WS2), we screened KITLG in suspected WS2-affected probands.
|
26522471 |
2015 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous mutations of MITF and its transactivator gene PAX3 are associated with Waardenburg syndrome type II (WS2) and type I (WS1), respectively.
|
22320238 |
2013 |
Waardenburg Syndrome Type 2
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Spectrum of novel mutations found in Waardenburg syndrome types 1 and 2: implications for molecular genetic diagnostics.
|
23512835 |
2013 |
Waardenburg Syndrome Type 2
|
0.800 |
Biomarker
|
disease |
CLINGEN |
MITF mutations associated with pigment deficiency syndromes and melanoma have different effects on protein function.
|
23787126 |
2013 |
Waardenburg Syndrome Type 2
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Functional analysis of MITF gene mutations associated with Waardenburg syndrome type 2.
|
23098757 |
2012 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Functional analysis of MITF gene mutations associated with Waardenburg syndrome type 2.
|
23098757 |
2012 |
Waardenburg Syndrome Type 2
|
0.800 |
Biomarker
|
disease |
BEFREE |
Screening of MITF and SOX10 regulatory regions in Waardenburg syndrome type 2.
|
22848661 |
2012 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A novel mutation in the MITF may be digenic with GJB2 mutations in a large Chinese family of Waardenburg syndrome type II.
|
22196401 |
2011 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in microphthalmia-associated transcription factor (MITF) lead to Waardenburg syndrome type 2 (WS2), a dominantly inherited disorder involving hearing loss and pigment disturbances caused by a lack of melanocytes.
|
20485200 |
2010 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Moreover, heterozygous mutations in the gene coding for microphthalmia-associated transcription factor, a key regulator for melanocyte development, are associated with Waardenburg syndrome type 2, an auditory-pigmentary disorder.
|
17347546 |
2007 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The deafness-pigmentary disorder Waardenburg Syndrome Type 2 is caused by mutations in the human Microphthalmia-associated transcription factor (MITF) gene.
|
15715979 |
2005 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutation in intron 6 of the hamster Mitf gene leads to skipping of the subsequent exon and creates a novel animal model for the human Waardenburg syndrome type II.
|
12871913 |
2003 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations of MITF in mice or humans with Waardenburg syndrome type 2 (WS2) often severely disrupt the bHLHZip domain, suggesting the importance of this structure.
|
10587587 |
2000 |
Waardenburg Syndrome Type 2
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Point mutation in the MITF gene causing Waardenburg syndrome type II in a three-generation Indian family.
|
9856573 |
1998 |
Waardenburg Syndrome Type 2
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Mutation at the anophthalmic white locus in Syrian hamsters: haploinsufficiency in the Mitf gene mimics human Waardenburg syndrome type 2.
|
9499424 |
1998 |
Waardenburg Syndrome Type 2
|
0.800 |
Biomarker
|
disease |
CTD_human |
Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA).
|
9158138 |
1997 |
Waardenburg Syndrome Type 2
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics.
|
8782819 |
1996 |
Waardenburg Syndrome Type 2
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics.
|
8782819 |
1996 |
Waardenburg Syndrome Type 2
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene.
|
7874167 |
1994 |